|Project name: ||National Proton Beam Therapy (PBT) Service Development Programme - there are 6 reports for this project: 2014, 2015, 2016, 2017, 2018, 2019 |
|Google search: ||Google search on project name (opens in new window) |
|Organisation: ||DOH (D12) - see all reports for this organisation |
|Report year: ||2017 (data is from Sept 2016) |
|Category: ||Infrastructure - see all reports for this category |
|Description: ||To develop a full Proton Beam Therapy service in England. |
|DCA (RAG): ||Amber |
|DCA text: ||The Programme - is assessed as being Amber for the following reasons:
UCLH flagged a number of construction issues at the National PBT Programme Board on 5 September 2016 and indicated that there was a risk of significant slippage to its first patient treatment date - a key programme milestone. Such slippage would impact on programme costs and the speed of transition to the new service.
Although UCLH is forecasting slippage against a key programme milestone, the Programme remains on plan to treat the first PBT patient in 2018 at The Christie, in accordance with the Prime Ministerial Commitment
Costs remain contained within the capital budget as approved in July 2015,
All recommendations from the November 2015 IPA Project Assessment Review have been acted upon/are being addressed by the PBT Programme.
NHS England will work closely with UCLH to re-plan the transition to the national service, and to confirm any financial impacts. UCLH will focus its work on negotiating a settlement with its building contractor and to implement changes to their programme that will serve to minimise the impact of the delay on the overall transition timeline and programme financials, and also to control and minimise further risk to the construction project. |
|Start date: ||2012-01-01 |
|End date: ||2018-05-30 |
|Schedule text: ||The National Proton Beam service remains on schedule to treat the first patient in the Summer of 2018 (at The Christie).
UCLH flagged a number of construction issues at the National PBT Programme Board on 5 September 2016 and indicated that their was a risk of significant slippage to its first patient treatment date - a key programme milestone. NHS England will work closely with UCLH in order to minimise the impact of the delay on the overall programme, and to control and minimise further risk to the construction elements of the timeline. |
|Baseline: ||£87.37m |
|Forecast: ||£67.32m |
|Variance: ||-23.00% |
|Variance text: ||Both Trusts have shown some phasing differences in reforecasts and this underspend is due to the Trusts re-profiling their draw down of capital in line with progress against their individual build timelines. |
|Whole Life Cost: ||£1,247.25m |
|WLCost text: ||Whole life costs - are composed of capital account (CDEL) and revenue account (RDEL) spend (at Nominal Pricing). The overall spend profile of the PBT Programme remains within Budgeted Whole Life Costs. The financial profile shows a large CDEL spend [£215 m (net of VAT and a Charitable contribution ~£20 m)] in the years to 2019/20 to build and equip the facilities, along with a relatively small RDEL spend to 2018/19 - covering interest, staff not involved in the development of the centres and training of clinical and technical staff prior to service commencement. From the date of service commencement (i.e. from The Christie first patient treatment date in August 2018), RDEL costs will start to ramp up to an annual cost of around £50m per annum (i.e. once UCLH is providing services). This £50m per annum spend covers the running of the two centres and treating of patients. All RDEL costs are to be paid for out of the NHS England budget for Specialised Services. |
|Notes1: || |
|Notes2: || |
|Sourcefile: ||IPA_2017.csv |
All Projects (+dates)
All Projects (+costs)
Acknowledgement: GMPP data has been re-used under the Open Government Licence.